Fate Therapeutics, Inc. (FATE) — Analysis Summary
Fate Therapeutics, Inc. (FATE) has a market cap of $331.03M with year-over-year revenue growth of -51.2%. Net margin stands at -2051.1%. The stock trades at a P/E ratio of -2.5.
Key Takeaways
- Revenue changed -51.2% year-over-year
- Net margin of -2051.1%
- P/E ratio of -2.5
Compared to other companies in the BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) sector, FATE posted revenue growth of -51.2% and trades at a P/E of -2.5.
Disclaimer: This is not financial advice. Data sourced from SEC EDGAR and Polygon.io. Past performance does not guarantee future results. Always conduct your own research before making investment decisions.